Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of delgocitinib ointment on skin barrier function in atopic dermatitis
jRCTs031200160Completed
- Sponsor
- Torii Pharmaceutical
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of budesonide in atopic dermatitis (AD) (2 arms), sponsored by Torii Pharmaceutical. Primary endpoints: Change in stratum corneum hydration and Change in transepidermal water loss. Started Nov 2020; status: completed.
02
Drugs
budesonide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCTs031200160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200160.